FOLD Q3 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+89.4% YoY

Gross Profit

$16M79.1% margin

Operating Income

-$156M-758.3% margin

Net Income

-$159M-772.8% margin

EPS (Diluted)

$-0.84

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

-$133M

Free Cash Flow

-$135M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$839M

Total Liabilities

$428M

Stockholders' Equity

$411M

Cash & Equivalents

$202M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$11M	+89.4%
Gross Profit	$16M	$9M	+79.3%
Operating Income	-$156M	-$275M	+43.3%
Net Income	-$159M	-$112M	-42.5%